【招银国际】Turnaround is here but weaker than expected.pdf

Sales exceeding expectations and achieving non-GAAP profitability

Core business recovery on track with more to expect on new initiatives

FY22 net margins better than expected

Expect steady growth with policy tailwinds

China Pharmaceutical & Healthcare - Expecting global funding recovery in the coming quarters

Is High Debt Constraining Monetary Policy? Evidence from Inflation Expectations

1H23 Preview: weak revenue amid industry headwinds; expect smartphone recovery in 2H23E

1H24 earnings down 27% YoY below our expectation; expect a better 2H24E

3Q24 earnings below expectations due to margin contraction

Expecting bottoming out